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Summary
Objective: Regeneration of the meniscal tissue occurs to a limited extent, and the loss of meniscal tissue leads to osteoarthritis. A new bio-
material consisting of hyaluronic acid and polycaprolactone was used as a meniscus substitute in sheep to evaluate the properties of the
implant material with regard to size, biomechanical stability, tissue ingrowth, and integration.
Methods: Eight sheep (right stiﬂe joints) were treated with three total and three partial meniscus replacements while two meniscectomies
served as empty controls. The animals were euthanized after 6 weeks. The specimens were assessed by gross inspection and histology,
and compared with the nonoperated left joints.
Results: The surgical technique was found to be feasible. The implants remained in position, did not tear, and showed excellent tissue
ingrowth to the capsule. Tissue integration was also observed between the original meniscus and the implant. However, graft compression
and extrusion occurred. The histological investigation revealed tissue formation, cellular inﬁltration and vascularization. Cartilage degeneration
was more severe in the operated joints.
Conclusion: The present study shows promising results concerning the qualities of this biomaterial with regard to implantation technique, sta-
bility and tissue ingrowth.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Cartilage
Repair
SocietyIntroduction
Injury to the meniscus or loss of meniscal tissue leads to
degeneration of cartilage and osteoarthritis1,2. Healing is
usually limited to the vascularized areas in the outer two
thirds of the meniscus3,4. Various techniques have been
used to improve healing, such as the introduction of a ﬁbrin
clot5, vascular access channels6, or gene transfer7. In
cases of extensive destruction and complete loss of the me-
niscus, allograft transplantation is one alternative. Meniscal
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Received 29 June 2005; revision accepted 4 April 2006.105allografts based on various preservation techniques (fresh,
fresh-frozen, cryopreserved) have been shown to heal to
the capsule and relieve pain. However, their long-term via-
bility, function and chondroprotective effect are still
unclear8. Ideally, a meniscal substitute should mimic the
shape and biomechanical properties of the meniscus.
Limitations were noted for several materials used as me-
niscus substitutes in vivo. Veth et al.9 employed carbon
ﬁber for meniscus repair in dogs, which resulted in ﬁbrous,
but not meniscus-like tissue formation. Small intestine sub-
mucosa used to repair posterior vascular meniscal defects
yielded satisfactory results in respect of tissue integration,
chondroprotection and limb function in dogs10, but the bio-
material has not yet been tested as a total meniscus substi-
tute. A few total meniscus substitutes have been described
in the published literature. A polyvinyl alcohol-hydrogel
meniscus in rabbits showed promising results in terms of
chondroprotection, but certain unresolved problems per-
sisted, such as the durability of the polymer, the ﬁxation
method, and complete tissue regeneration in a material that6
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rous polyester urethane polymers as meniscus prostheses
in dogs. Although they showed similar promising results in
respect of tissue formation, one of the materials (aromatic
4,4,-diphenylmethanediisocynatebased) is known todegrade
into toxic products. This phenomenon is believed to be less
pronounced when the modiﬁed aliphatic 1,4-butanediisocya-
nate-based polyester urethane is used; however, the differ-
ence is not proven.
The collagen meniscus implant (CMI) (ReGen Biologics,
Inc., Franklin Lakes, NJ, USA) is the most advanced tech-
nique for meniscus regeneration. It is the only method
used so far in a clinical setting12e14. Despite improvements
in pain and self-evaluation15, the histological results are
controversial. Rodkey et al.15 reported that remnants of
the CMI were present after 6 months and 1 year. However,
in three patients who underwent a biopsy after 5e6 years,
there was no evidence of remnants of the CMI14. In the
above mentioned biopsies, the regenerated tissue was sim-
ilar to the meniscus, with a uniform collagenous extracellu-
lar matrix and ﬁbrochondrocytes. In contrast, Martinek
et al.16 report inferior histological results: matrix production
occurred in some areas while the tissue presented as scar
tissue and differed markedly from ﬁbrocartilage. In a sheep
model, preseeding of the CMI with ﬁbrochondrocytes led to
gross, as well as histological, improvement of the implant.
However, the tissue-engineered meniscus was biomechan-
ically unstable and the implant size reduced during the
observation period of 3 months. Thus, the construction of
a biomechanically stable meniscal substitute with a micro-
structure similar to the native meniscus still poses
a challenge17.
A new resorbable biomaterial consisting of hyaluronic
acid and polycaprolactone (PCL), developed to serve either
as a partial or a total meniscus substitute, was tested in an
in vivo study in sheep. The aim of the present study was to
evaluate the properties of the biomaterial with regard to
size, mechanical stability and tissue ingrowth in early
stages after implantation (6 weeks).
Methods
STUDY DESIGN
All procedures were approved by the local ethics commit-
tee for animal studies (GZ 66.009/114-BrGT/2004). Eight
skeletally mature Austrian stone sheep (50e64 kg), dividedinto two groups, were subjected to arthrotomy of the right
stiﬂe joint. The TM group (total meniscus replacement,
n¼ 3) received total medial meniscectomy and a total
meniscus implant, while the PM group (partial meniscus re-
placement, n¼ 3) underwent resection of the anterior
portion of the medial meniscus and received a partial
implant. The left stiﬂe joints served as nonoperated joints
for comparison. Each group had an empty control (without
implant) (TM, n¼ 1; PM, n¼ 1).
BIOMATERIAL
The scaffold is a porous composite of PCL and HYAFF,
a class of hyaluronan-derived polymers obtained by a cou-
pling reaction (Fidia Advanced Biopolymers, Abano Terme,
Italy), with a pore size of 200e300 mm (Fig. 1). The menis-
cus-like devices were produced by a lamination technique
using moulds that were designed according to original
sheep menisci. PCL (Aldrich, 181609, batch 02101LI) solu-
tion and HYAFF-11 p75 HE (FAB, lot 013100) powder at
a ratio of PCL/HYAFF-11 p75 HE 70/30 are mixed with
salts (size range: 315e400 mm) until a homogenous paste
is obtained. The ratio between the polymers and the salts is
1/10. The salts increase the porosity of the structure and
ensure intercommunication between the pores. Two types
of implants were constructed: the total meniscus device
was augmented with circumferential polylactic acid (PLA)
ﬁbers, which protruded at the anterior and posterior horns
and could be pulled through transosseous tunnels
[Fig. 2(a)]; the partial meniscus device was augmented
with a polyethylene terephtalate (PET) net (Mersuturesd
Ethicon, g ray sterilized 25 kGy) in order to keep the su-
tures ﬁxed to the residual meniscus [Fig. 2(b)]. The PET
net and the PLA ﬁbers were augmented by partially ﬁlling
the mould with the paste. Subsequently, the net or ﬁbers
were arranged in the mould and the remaining paste was
used to ﬁll it. The length of the implants was 32 mm and
the diameter, 22 mm. The height of the implant at the
periphery was 6 mm in the PM group. In the TM group,
two 6-mm- and one 8-mm-high (in a bigger sheep) implants
were used.
The in vivo degradation time can be estimated on the
basis of the behavior of the individual components. PCL
degrades slowly by hydrolytic chain scission of the ester
linkage18. PCL loses its in vivo molecular weight slowly
(up to 12 months, depending on the polymer composition),
but loses its mechanical stability much earlier (between 12Fig. 1. (a) A micro CT image shows the cross-section of the implant with the horizontally oriented net in the lower third of the implant. (b) A
scanning electron microscopy image demonstrates the porous structure of the implant with a pore size of 200e300 mm.
1058 C. Chiari et al.: Tissue engineering in meniscus regenerationFig. 2. (a) The total meniscus implant is augmented with circumferential PLA ﬁbers, which are pulled into the transosseous tunnels. (b) The
partial meniscus implant is reinforced with a PET net and its size is adjusted with a scalpel to ﬁll the defect in the anterior portion of the
meniscus.and 16 weeks)19. HYAFF-11 degrades by deesteriﬁcation
in 3e4 months in vivo20.
SURGICAL PROCEDURE
Surgery was conducted under general anesthesia. A
blood analysis was performed. The sheep received 2.5 g
metamizol and 1 g cefazoline twice daily until the third post-
operative day. Degenerative joint disease and skeletal
abnormalities were excluded by preoperative radiographic
examination. Prior to implantation, the implants were
soaked in physiological saline within a closed 50-ml syringe
under vacuum created by pulling the stamp. An anterome-
dial arthrotomy was performed.
TM GROUP
In the TM group [Fig. 3(a)], the medial collateral ligament
(MCL) was cut slightly above the joint line. This was neces-
sary in order to achieve good exposure of the posterior
aspect of the joint. The meniscus was circumferentially
dissected from the capsule; the posterior horn of the
Fig. 3. (a) TM group: total medial meniscectomy, the MCL is cut, the
implant ﬁxed to the capsule with sutures via two transosseous drill
holes, and the MCL is reconstructed. (b) PM group: partial medial
meniscectomy of the anterior part. The MCL is intact, and the
implant is sutured to the anterior crucial ligament, the remnant of
the original meniscus and the capsule.meniscus was exposed by ﬂexion, external rotation and val-
gus stress of the joint, and the meniscus was detached at its
posterior and anterior horns. Two 3-mm tunnels were drilled
with a guidewire from the medial tibial condyle to the foot-
prints of the anterior and posterior meniscal horns. The
implant was ﬁxed with two nonresorbable anchoring sutures
(Ethibond Excel 2-0, Ethicon GmbH, Norderstedt, Germany)
inserted through the implant at its horns. The sutures were
pulled through the bone tunnels and tied to each other in
a knot on the tibial surface. Two silk threads were tied to
the PLA ﬁbers protruding from the implant at its horns
(Fig. 2), and pulled into the bone tunnels. The capsule was
closed (Vicryl 3-0, Ethicon GmbH, Norderstedt, Germany).
Simultaneously, several additional sutures were made
between the implant and the capsule. The anterior and poste-
rior horns of the implant were ﬁxed to the meniscal ligaments
(Vicryl 4-0, EthiconGmbH,Norderstedt, Germany). TheMCL
was reconstructed with four sutures, using resorbable
sutures (Vicryl 2-0, Ethicon GmbH, Norderstedt, Germany).
PM GROUP
In the PM group [Fig. 3(b)], the anterior portion of the
meniscus was exposed by detaching the capsule at the pe-
riphery while the MCL was left intact. The anterior portion of
the meniscus was cut out radially at the level of the MCL.
The size of the implant was adjusted using a scalpel, so
that it corresponded to the resected portion of the meniscus.
The implant was then sutured to the remaining portion of the
meniscus and to the remnants of the anterior horn ﬁxation
near the anterior cruciate ligament (Vicryl 4-0, Ethicon
GmbH, Norderstedt, Germany). The capsule was closed
(Vicryl 3-0, Ethicon GmbH, Norderstedt, Germany). Simul-
taneously, several additional sutures were made between
the implant and the capsule (Vicryl 4-0, Ethicon GmbH,
Norderstedt, Germany).
EMPTY CONTROLS
The empty controls were operated on in the same man-
ner, except for the fact that the meniscus device was not
implanted. The skin was closed using the standard surgical
technique.
All sheep received an external plaster (Scotch/Soft Cast,
3 M Health Care, St Paul, MN, USA) to limit motion at the
operated limb for 5 days, as described previously21. Free
movement within the cage was permitted immediately after
surgery. After 2 weeks, the stitches were removed and the
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observation period.
SPECIMEN PREPARATION AND GROSS INSPECTION
The sheep were euthanized 6 weeks after surgery with
an overdose of barbiturate (Pentobarbital Sodium CII eutha-
nasia solution, 0.6 mg/kg) in general anesthesia, followed
by potassium chloride, until cardiac arrest was achieved.
A follow-up blood analysis to detect infection or allergic
reactions, and a radiographic examination were performed.
The joints were evaluated clinically for swelling and stability.
Under sterile conditions the right and the left joints were
opened through the previous approach, a swab for microbi-
ological analysis and a synovial aspirate were taken, and
the presence of effusion or popliteal cysts was documented.
The joint was resected in toto, and the restoration of the
MCL was inspected. The implant’s ﬁxation to the capsule,
anterior and posterior horn attachment (group TM only),
the implant’s ﬁxation to the remaining meniscus (group
PM only), and the location of the implant were noted. Joint
status was assessed using the Gross Assessment of Joint
changes Score published by Jackson et al.22, which scores
12 different areas of the joint, including the femoral and tib-
ial cartilage, the patella, its femoral groove, the menisci and
the femoral junction. The specimens were photographed
and then ﬁxed in 10% neutral buffered formalin.
HISTOLOGY
The femoral and the tibial portions of the specimen were
separated and decalciﬁcation was performed with ethylene-
diaminetetraacetic acid (EDTA) 10%. The menisci were left
attached to the tibia and the tibial plateau. In the TM group,
the medial tibial plateaus were cut like a pie in order to ob-
tain representative histological specimens of the anterior
and posterior horn, the MCL region and the anterior andposterior intermediate parts. The PM group was processed
in the same manner. However, additional cuts were per-
formed here to assess the contact area between the implant
and the original meniscus. The femoral condyle was divided
into an inner and an outer region, and the cartilage was as-
sessed in the anterior, central and posterior regions (six
areas per condyle). In detail, the condyle was cut longitudi-
nally in two halves with the bone saw. Each half was further
cut into two slices, thus achieving a central section through
the outer and the inner half. In each section the cartilage
was assessed in the anterior, central and posterior third
(Fig. 4). A synovial biopsy from the medial compartment ad-
jacent to the meniscal implant was taken from each joint. A
routine histological investigation with parafﬁn embedding
and 3-mm cuts was performed. The specimens were stained
with hematoxylin/eosin (HE) for general morphology, safra-
nin O/fast green for glycosaminoglycans (GAG), and Azan
for collagen. A mapping system for the implant was created,
dividing the implant into a peripheral (zone 1), an intermedi-
ate (zone 2) and a central (zone 3) zone. Besides, a super-
ﬁcial (zone s) and a core (zone c) zone were determined.
The cartilage beneath the implant was assessed in the pe-
riphery (cart-p) and the center (cart-c) [Fig. 5(b)]. Bonding of
the implant to the capsule was noted. The cartilage was
scored using a modiﬁed Mankin score23,24, assessing carti-
lage surface, GAG content, cellularity and cloning. Sections
from two normal knees which had not been operated on
served as normal controls.
Results
SURGERY
Intraoperative findings
In general, the implant material was feasible in terms of
surgical handling. Neither the anchoring sutures nor theFig. 4. (a) The femoral condyle was cut longitudinally with the band saw into two halves, which were divided again. The central section of the
inner (i) and outer (o) part was evaluated. (b) The longitudinal section of the condyle was assessed in the anterior (ant), central (cent) and
posterior (post) third. (c) Reconstruction of a representative photomicrograph of the femoral condyle (HE staining, magniﬁcation 1).
1060 C. Chiari et al.: Tissue engineering in meniscus regenerationFig. 5. (a) Photomicrograph reconstruction showing peripheral tissue bonding between the implant (imp) and the capsule (cap), tissue ingrowth
and coverage of the surface. Collagen is stained blue (Azan staining, original magniﬁcation 1). (b) Mapping system for histological assess-
ment of the implant’s cross-sections, evaluating three zones from the periphery to the center (zone 1, 2, 3), the surface (s) and the core (c)
area, and the tibial cartilage in the peripheral (cart-p) and central (cart-c) contact area with the implant. (c) Photomicrograph showing tissue
bonding in the contact area (con) between the implant (imp) and the residual meniscus (men) in the PM group. Collagen is stained blue (Azan
staining, original magniﬁcation 4). (d) Photomicrograph showing giant cells (G) and ﬁbroblasts (F) surrounding the biomaterial (B) (HE stain-
ing, original magniﬁcation, 40).sutures between the implant and the capsule or the rem-
nants of the original menisci cut through thematerial. Dissec-
tion of the MCL provided good exposure of the posterior joint
space, which proved essential for correct positioning of the
posterior drill hole and the posterior horn of the implant. Re-
construction of the MCL with sutures, as described above,
was simple to perform and immediately stable.
GROSS INSPECTION
Comparison of postoperative and preoperative radio-
graphs revealed no signs of degeneration. Six knees (two
total replacements, two partial replacements, two empty
controls) showed a soft tissue swelling in the medial aspect.
All joints were stable.
TM group
All three implants showed excellent capsular ingrowth at
the periphery [Fig. 6(aec)]. The anterior horns were ﬁrmly
attached, except for two joints [Fig. 6(a, c)] in which the pos-
terior horns were detached from the anchoring sutures. The
surface of the biomaterial was completely covered with
a shiny, smooth synovium-like tissue, which showed signs
of blood vessel formation. The menisci prototypes had
maintained their shape and size and revealed no tears.
All implants had been compressed under loading condi-
tions. Thus, a slight extrusion of the implants at the periph-
ery and a wrinkling in the posterior region were seen,probably causing mechanical problems and the detachment
of the horns in the posterior aspect of the joint space
[Fig. 6(aec)]. These ﬁndings were most distinct in the joint
treated with the higher 8-mm implant [Fig. 6(c)]. The recon-
struction of the MCL had healed in all three cases. In all
joints, the capsules where the arthrotomy had been per-
formed were thickened. This was also present in the total
meniscectomy control, which showed a small circumferen-
tial rim of regenerate tissue [Fig. 6(d)].
PM group
All three partial meniscus implants were attached to the
anterior horn and showed excellent capsular ingrowth in
the periphery [Fig. 6(eeg)]. The main issue investigated in
the partial meniscus replacement model was the integration
of the biomaterial into the original meniscus. This was
achieved, as gross examination revealed the formation of
tissue in the contact area between the biomaterial and the
original meniscus in two of three cases [Fig. 6(e, g)]. The
implants retained their shape and developed no tears. Two
implants were slightly large and had been extruded out of
the joint space [Fig. 6(e, g)]. Again, as in the TM group,
the biomaterial was covered by synovium-like tissue and
showed signs of vascularization. In one case a net was vis-
ible on the surface [Fig. 6(e)]. The capsule was thickened at
the site of arthrotomy. In the partial meniscectomy control,
a considerable amount of regenerate tissue, ﬁlling approxi-
mately one quarter of the defect had developed [Fig. 6(h)].
Fig. 6. Total medial meniscus replacement 6 weeks after implantation (aec) and total meniscectomy control (d). All implants show good
peripheral ingrowth to the capsule. Surface irregularities were seen in the posterior part of the implant. Partial replacement of the anterior
part of the medial meniscus 6 weeks after implantation (eeg) and partial meniscectomy control (f). All implants show good ingrowth to the
capsule, a tissue bridge is present between the implant and the original meniscus. The empty control shows spontaneous regenerative tissue
ﬁlling of about one quarter of the defect. (F¼ femur, T¼ tibia, AH¼ anterior horn, PH¼ posterior horn, I¼ implant).
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The results of gross assessment of joint changes score
for the operated and the nonoperated knee joints are pre-
sented in Tables I and II. The operated joints showed
a higher degree of degeneration than did the nonoperated
joints. The mean summative scores of the total and partial
meniscectomy controls were 11 and 12, respectively.
HISTOLOGY
Implant
A total of 21 histological sections of the implants could be
evaluated. The histological investigation revealed excellent
bonding between the implant and the capsule [Fig. 5(a)] in
all specimens. In the PM group, ﬁbrous tissue had formed
between the biomaterial and the residual of the original me-
niscus [Fig. 5(c)], which conﬁrmed the gross impression of
the biomaterial’s integration into the original meniscus.
Moreover, all histological sections showed tissue formation
from the periphery (zone 1) to the innermost zone (zone 3)
in both, the superﬁcial (zone s) and the core (zone c) as-
pects of the implant. The tissue covering the implant resem-
bled synovial tissue. Blood vessels had formed in the
superﬁcial zone (zone s) in all sections, and in the core
zone (zone c) in about two thirds of the sections. All spec-
imens showed accumulation of giant cells in contact with
Table I
Gross assessment of joint changes scoredtotal meniscus
replacement
Anatomic site Knee* Mean
grade
Distribution of grades
0 1 2 3 4
Anterior medial
femoral condyle
N 0.3 2 1 0 0 0
O 1.3 0 2 1 0 0
Posterior medial
femoral condyle
N 0 3 0 0 0 0
O 1.3 1 2 1 0 0
Anterior lateral
femoral condyle
N 0.3 2 1 0 0 0
O 1 2 0 0 1 0
Posterior lateral
femoral condyle
N 0 3 0 0 0 0
O 1 2 0 0 1 0
Patellar femoral
groove
N 1.3 1 1 0 1 0
O 2.3 0 1 2 0 0
Patella articular
surface
N 1 2 0 1 0 0
O 1.7 0 1 2 0 0
Medial tibial plateau N 1 1 1 1 0 0
O 1 0 3 0 0 0
Lateral tibial plateau N 1.3 0 2 1 0 0
O 0 3 0 0 0 0
Medial meniscus N 0 3 0 0 0 0
O 1.7 0 2 0 1 0
Lateral meniscus N 0 3 0 0 0 0
O 0 3 0 0 0 0
Osteophytes N 0 3 0 0 0 0
O 0 3 0 0 0 0
Condyle groove
junction
N 0 3 0 0 0 0
O 1 2 0 0 1 0
Mean summative
score
N 5.2
O 12.3
*N, nonoperated leg; O, operated leg.the biomaterial, interspersed with ﬁbroblast-like cells
[Fig. 5(d)] (Table III).
CARTILAGE
Tibia
In general, degeneration of cartilage was more severe in
the TM group than in the PM group, resulting in a notably
higher histologic score in the TM group [Fig. 7(c, d)]. The
tibial cartilage underneath the implant was covered by tis-
sue that resembled synovial tissue, which was interpreted
as the formation of pannus. Pannus formation decreased
from the periphery (cart-p) towards the center of the tibial
plateau (cart-c). The implant-free controls demonstrated
similar behavior.
Table II
Gross assessment of joint changes scoredpartial meniscus
replacement
Anatomic site Knee* Mean
grade
Distribution of grades
0 1 2 3 4
Anterior medial
femoral condyle
N 0.3 2 1 0 0 0
O 1.6 0 1 2 0 0
Posterior medial
femoral condyle
N 0.3 2 1 0 0 0
O 1 1 1 1 0 0
Anterior lateral
femoral condyle
N 0 3 0 0 0 0
O 0 3 0 0 0 0
Posterior lateral
femoral condyle
N 0 3 0 0 0 0
O 0 3 0 0 0 0
Patellar femoral
groove
N 1.3 1 0 2 0 0
O 2 0 0 3 0 0
Patella articular
surface
N 0.7 2 0 1 0 0
O 1.3 1 0 2 0 0
Medial tibial plateau N 0.3 2 1 0 0 0
O 0.7 1 2 0 0 0
Lateral tibial plateau N 0 3 0 0 0 0
O 0 3 0 0 0 0
Medial meniscus N 0 3 0 0 0 0
O 2.3 0 0 2 1 0
Lateral meniscus N 0 3 0 0 0 0
O 0 3 0 0 0 0
Osteophytes N 0 3 0 0 0 0
O 0 3 0 0 0 0
Condyle groove
junction
N 0 3 0 0 0 0
O 0 3 0 0 0 0
Mean summative
score
N 5.8
O 8.9
*N, nonoperated leg; O, operated leg.
Table III
Histological evaluation of the implant
Sections, n¼ 21 Zone 1 Zone 2 Zone 3
Giant cells 21 21 20
Tissue ingrowth 21 21 20
Tissue coverage 21 21 21
Sections, n¼ 21 Zone s Zone c
Vessel ingrowth 21 13
1063Osteoarthritis and Cartilage Vol. 14, No. 10Fig. 7. Average Mankin scores of the operated and the nonoperated joints, and the corresponding empty meniscectomy control. (a) Femur, TM
group; (b) tibia, PM group; (c) tibia, TM group; (d) femur, PM group.Compared to the average scores of the implant group, the
empty controls revealed a higher degree of cartilage degen-
eration with the exception of the posterior portion of the tib-
ial cartilage in the TM group, which was more severely
degenerated than the corresponding portion in the empty
control. The tibial cartilage of the nonoperated left joints
was only slightly degenerated.
Femur
Cartilage was less damaged in the femoral aspect than in
the tibial aspect. Moreover, the histological scores differed
slightly between the TM group and the PM group, with
a marginally better outcome for the former [Fig. 7(a, b)].
The histological scores of the empty control were compara-
ble with those of the PM implant group, but slightly lower for
the TM group.
Synovial aspirate
The microbiological swabs did not show any signs of
infection. The results of the synovial smears were identical
for all animals (including the empty controls): lymphocytes,
but no cells indicating acute inﬂammation or foreign body
reaction were found.
Discussion
Meniscus regeneration and its replacement with biomate-
rials are issues of current interest in orthopedic research.
Experimental studies concerning synthetic devices made
of polyurethane25,26, polytetraﬂuoroethylene27 and polyes-
ter carbon28 as possible alternatives to meniscus allografts
yielded unsatisfactory results in terms of biocompatibility,
material properties and chondroprotection. In a dog model,
the resorbable bovine collagen scaffold for the regeneration
of meniscal tissue developed by Stone et al.12,29 showed
host tissue ingrowth and the formation of ﬁbrocartilageresembling a normal canine meniscus after 9 and 12
months12.
The CMI, when applied in the clinical setting, requires
a peripheral meniscus rim for its ﬁxation and is therefore
unsuitable for total meniscus replacement. A clinical trial
concerning CMI revealed newly formed collagen after 3e6
months13, but long-term results and evidence of chondro-
protection are still pending. Polymer scaffolds have been
used for meniscal lesion repair, and showed tissue ingrowth
as well as the formation of ﬁbrocartilaginous tissue30,31. To
our knowledge, the present study is the only in vivo investi-
gation of a resorbable biopolymer used for partial and total
meniscus replacement.
MENISCUS REGENERATION
In general, the biomaterial showed excellent properties in
terms of mechanical stability and tissue ingrowth. The
implants maintained their shape and remained in position.
They were also ﬁrmly bonded to the capsule, completely
covered by a synovium-like tissue, and revealed signs of
vessel formation. However, the majority of the implants
had been compressed, which caused graft extrusion to
the periphery and into the posterior joint space, as well as
irregularities and wrinkles on the implant’s surface. Exact
sizing or even undersizing could help to resolve this prob-
lem. Tissue ingrowth and overgrowth might also have
been partly responsible for the different appearance of
size. The material can be tailored intraoperatively with
a scalpel according to the individual situation. This is an
advantage compared to meniscus allograft transplantation,
where the problems of sizing and graft shrinkage are still
unresolved8. The problem of compression and extrusion
cannot be transferred from the animal model to the human
setting. Despite immobilization in the cast, full weight bear-
ing cannot be completely avoided in a sheep model32. Con-
trolled rehabilitation with limited weight bearing and range of
motion in humans will reduce these problems.
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partial (PM group) meniscus replacement. Obviously, a total
meniscus prosthesis would serve as an alternative to
meniscus allografts in cases of complete loss of the menis-
cus. In cases of partial meniscus defects, one is usually
confronted with loss of the inner portions of the meniscus;
only a peripheral rim remains. In the PM group, a different
type of defect was created (anterior partial resection with
the MCL left untouched). This defect may not reﬂect the
clinical situation. However, this type of partial resection
was selected in order to study the integration of the implant
to the residual meniscus throughout its radial diameter. Tis-
sue formation in the contact area between the meniscus
and the implant was demonstrated on gross as well as
microscopic inspection after 6 weeks. Thus, the capacity
of the biomaterial to serve as a device for meniscus regen-
eration in cases of partial loss of the meniscus is promising.
Histological analysis of the implant material conﬁrmed the
gross ﬁndings: tissue formation and bonding to the capsule,
as well as soft tissue formation, had occurred all through to
the core zone of the implant. In cases of partial meniscus re-
section, Azan staining showed that collagen ﬁbers had ﬁlled
the gap between the biomaterial and original meniscus, indi-
cating that a process of integration was under way. A layer of
tissue had formed all over the surface of the implant
[Fig. 4(a)]. Furthermore, a large number of blood vessels
had developed, growing from the superﬁcial to the central
areas of the biomaterial [Fig. 4(d)]. Our ﬁndings are similar
to those achieved with 3-month samples of the CMI dog
model, where immature vascular connective tissuewith ﬁbro-
blasts, numerous capillaries and a ﬁne ﬁbrillar matrix were
seen12. The impact of the giant cell reaction is difﬁcult to es-
timate. Giant cells were seen after 6 weeks, as part of the
physiological resorption process20,33. Neither the synovial bi-
opsies nor the smears revealed acute inﬂammatory cells.
DEGENERATION OF CARTILAGE
The results of cartilage degeneration must be interpreted
with caution. Six weeks is deﬁnitely too early to draw reliable
conclusions, as shown by Rijk et al.34 In the latter study,
meniscus transplantation exerted no chondroprotective
effect after 6 weeks, but did so after 1 year. We believe
that physiological healing processes are not completed at
this early point in time. The formation of pannus below the
implant was similar to that seen in the meniscectomied
knee joints and is likely to have been caused by the arthrot-
omy itself. Furthermore, the fact that degeneration of carti-
lage was generally more severe in all operated joints
compared to nonoperated ones might have resulted from
the surgical intervention and not the implant alone.
In the TM group the marked changes in the posterior as-
pect were presumably related to mechanical problems and
high pressure forces causing implant irregularities and the
detachment of the horns in this portion of the joint. Long-
term studies are needed to determine the chondroprotective
potential of the implant, especially when compared to allo-
graft techniques24,34e37.
A new resorbable biomaterial consisting of PCL and
HYAFF-11 was introduced for meniscus replacement in
a sheep model. No animals or implants were lost and no
adverse events were encountered. The properties of the
biomaterial in terms of tissue meniscus regeneration are
promising: the implants remained in position, retained their
shape, and showed adequate mechanical properties. How-
ever, compression of the implant led to extrusion, whichmainly occurred in the posterior aspect. Complete ongrowth
to the capsule and the formation of tissue between the
implant and the original meniscus in the partial replace-
ments, seen on gross inspection as well as histology,
provided evidence of implant integration after 6 weeks.
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